ID   ELAV1_RAT               Reviewed;         326 AA.
AC   B5DF91;
DT   11-MAY-2016, integrated into UniProtKB/Swiss-Prot.
DT   14-OCT-2008, sequence version 1.
DT   27-MAR-2024, entry version 115.
DE   RecName: Full=ELAV-like protein 1 {ECO:0000305};
DE   AltName: Full=Hu-antigen R;
DE            Short=HuR;
GN   Name=Elavl1 {ECO:0000312|RGD:1308649};
GN   Synonyms=Hur {ECO:0000312|EMBL:BAG72208.1};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116 {ECO:0000312|EMBL:AAI68972.1};
RN   [1] {ECO:0000312|EMBL:BAG72208.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH HNRNPL, SUBCELLULAR LOCATION,
RP   AND RNA-BINDING.
RX   PubMed=18161049; DOI=10.1002/hep.22036;
RA   Matsui K., Nishizawa M., Ozaki T., Kimura T., Hashimoto I., Yamada M.,
RA   Kaibori M., Kamiyama Y., Ito S., Okumura T.;
RT   "Natural antisense transcript stabilizes inducible nitric oxide synthase
RT   messenger RNA in rat hepatocytes.";
RL   Hepatology 47:686-697(2008).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart {ECO:0000312|EMBL:AAI68972.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-202, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: RNA-binding protein that binds to the 3'-UTR region of mRNAs
CC       and increases their stability (By similarity). Involved in embryonic
CC       stem cell (ESC) differentiation: preferentially binds mRNAs that are
CC       not methylated by N6-methyladenosine (m6A), stabilizing them, promoting
CC       ESC differentiation (By similarity). Has also been shown to be capable
CC       of binding to m6A-containing mRNAs and contributes to MYC stability by
CC       binding to m6A-containing MYC mRNAs (By similarity). Binds to poly-U
CC       elements and AU-rich elements (AREs) in the 3'-UTR of target mRNAs.
CC       Binds avidly to the AU-rich element in FOS and IL3/interleukin-3 mRNAs.
CC       In the case of the FOS AU-rich element, binds to a core element of 27
CC       nucleotides that contain AUUUA, AUUUUA, and AUUUUUA motifs. Binds
CC       preferentially to the 5'-UUUU[AG]UUU-3' motif in vitro (By similarity).
CC       With ZNF385A, binds the 3'-UTR of p53/TP53 mRNA to control their
CC       nuclear export induced by CDKN2A. Hence, may regulate p53/TP53
CC       expression and mediate in part the CDKN2A anti-proliferative activity.
CC       May also bind with ZNF385A the CCNB1 mRNA (By similarity). Increases
CC       the stability of the leptin mRNA harboring an AU-rich element (ARE) in
CC       its 3' UTR (By similarity). {ECO:0000250|UniProtKB:P70372,
CC       ECO:0000250|UniProtKB:Q15717}.
CC   -!- SUBUNIT: Monomer and homodimer (in vitro). Interacts with ANP32A (By
CC       similarity). Interacts with ZNF385A; the interaction is indirect and
CC       mRNA-dependent and may regulate p53/TP53 expression (By similarity).
CC       Identified in a mRNP complex, at least composed of DHX9, DDX3X, ELAVL1,
CC       HNRNPU, IGF2BP1, ILF3, PABPC1, PCBP2, PTBP2, STAU1, STAU2, SYNCRIP and
CC       YBX1. Interacts with AGO1 and AGO2. Interacts with IGF2BP1. Interacts
CC       with IGF2BP2 and IGF2BP3 (By similarity). Interacts with HNRNPL
CC       (PubMed:18161049). Interacts with DHX36; this interaction occurs in a
CC       RNA-dependent manner. Interacts with ILF3; this interaction occurs in a
CC       RNA-dependent manner (By similarity). Interacts with PLEKHN1 (By
CC       similarity). Interacts with SHFL; the interaction increases in presence
CC       of RNA (By similarity). Interacts with YBX1; interaction recruits
CC       ELAVL1 on C5-methylcytosine (m5C)-containing mRNAs, thereby promoting
CC       mRNA stability (By similarity). Interacts with FXR1 (By similarity).
CC       {ECO:0000250|UniProtKB:P70372, ECO:0000250|UniProtKB:Q15717,
CC       ECO:0000269|PubMed:18161049}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:18161049}. Nucleus
CC       {ECO:0000250|UniProtKB:Q15717}. Cytoplasm, Stress granule
CC       {ECO:0000250|UniProtKB:P70372}. Cytoplasm, P-body
CC       {ECO:0000250|UniProtKB:Q15717}. Note=Translocates into the cytoplasm
CC       following phosphorylation by MAPKAPK2. Likewise, phosphorylation by
CC       PRKCD promotes translocation from the nucleus into the cytoplasm, where
CC       it is associated with free and cytoskeleton-bound polysomes. Localizes
CC       to the stress granules in the presence of PLEKHN1.
CC       {ECO:0000250|UniProtKB:Q15717}.
CC   -!- DOMAIN: The first RRM (RNA recognition motif) domain is essential for
CC       binding to AU-rich elements. {ECO:0000250|UniProtKB:Q15717}.
CC   -!- PTM: Phosphorylated by MAPKAPK2. Phosphorylated by PRKCD.
CC       {ECO:0000250|UniProtKB:Q15717}.
CC   -!- PTM: Methylated at Arg-217 by CARM1 in macrophages in response to LPS
CC       challenge. {ECO:0000250|UniProtKB:Q15717}.
CC   -!- SIMILARITY: Belongs to the RRM elav family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB212679; BAG72208.1; -; mRNA.
DR   EMBL; AABR07034979; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH474084; EDL75000.1; -; Genomic_DNA.
DR   EMBL; CH474084; EDL75001.1; -; Genomic_DNA.
DR   EMBL; BC168972; AAI68972.1; -; mRNA.
DR   RefSeq; NP_001102318.1; NM_001108848.1.
DR   AlphaFoldDB; B5DF91; -.
DR   SMR; B5DF91; -.
DR   CORUM; B5DF91; -.
DR   IntAct; B5DF91; 4.
DR   STRING; 10116.ENSRNOP00000001415; -.
DR   iPTMnet; B5DF91; -.
DR   PhosphoSitePlus; B5DF91; -.
DR   jPOST; B5DF91; -.
DR   PaxDb; 10116-ENSRNOP00000001415; -.
DR   PeptideAtlas; B5DF91; -.
DR   Ensembl; ENSRNOT00000001415.7; ENSRNOP00000001415.5; ENSRNOG00000001069.7.
DR   Ensembl; ENSRNOT00055006628; ENSRNOP00055005075; ENSRNOG00055004143.
DR   Ensembl; ENSRNOT00060004044; ENSRNOP00060002868; ENSRNOG00060002516.
DR   Ensembl; ENSRNOT00065008750; ENSRNOP00065006198; ENSRNOG00065005840.
DR   GeneID; 363854; -.
DR   KEGG; rno:363854; -.
DR   UCSC; RGD:1308649; rat.
DR   AGR; RGD:1308649; -.
DR   CTD; 1994; -.
DR   RGD; 1308649; Elavl1.
DR   eggNOG; KOG0145; Eukaryota.
DR   GeneTree; ENSGT00940000155528; -.
DR   HOGENOM; CLU_026186_2_2_1; -.
DR   InParanoid; B5DF91; -.
DR   OMA; NQMRYNN; -.
DR   OrthoDB; 129910at2759; -.
DR   PhylomeDB; B5DF91; -.
DR   TreeFam; TF313377; -.
DR   Reactome; R-RNO-450520; HuR (ELAVL1) binds and stabilizes mRNA.
DR   PRO; PR:B5DF91; -.
DR   Proteomes; UP000002494; Chromosome 12.
DR   Proteomes; UP000234681; Chromosome 12.
DR   Bgee; ENSRNOG00000001069; Expressed in thymus and 20 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IDA:ARUK-UCL.
DR   GO; GO:0010494; C:cytoplasmic stress granule; ISS:UniProtKB.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:ARUK-UCL.
DR   GO; GO:0000932; C:P-body; IEA:UniProtKB-SubCell.
DR   GO; GO:0098794; C:postsynapse; ISO:RGD.
DR   GO; GO:1990904; C:ribonucleoprotein complex; ISS:UniProtKB.
DR   GO; GO:0016528; C:sarcoplasm; ISO:RGD.
DR   GO; GO:0003725; F:double-stranded RNA binding; ISO:RGD.
DR   GO; GO:0106222; F:lncRNA binding; ISO:RGD.
DR   GO; GO:0035198; F:miRNA binding; ISS:UniProtKB.
DR   GO; GO:0035925; F:mRNA 3'-UTR AU-rich region binding; ISS:UniProtKB.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; IDA:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0003723; F:RNA binding; ISO:RGD.
DR   GO; GO:0070935; P:3'-UTR-mediated mRNA stabilization; ISS:UniProtKB.
DR   GO; GO:0061157; P:mRNA destabilization; IMP:RGD.
DR   GO; GO:0048255; P:mRNA stabilization; ISS:UniProtKB.
DR   GO; GO:0060965; P:negative regulation of miRNA-mediated gene silencing; ISS:UniProtKB.
DR   GO; GO:0032930; P:positive regulation of superoxide anion generation; IMP:RGD.
DR   GO; GO:0045727; P:positive regulation of translation; ISO:RGD.
DR   GO; GO:0016441; P:post-transcriptional gene silencing; ISO:RGD.
DR   GO; GO:0051260; P:protein homooligomerization; ISS:UniProtKB.
DR   GO; GO:0006606; P:protein import into nucleus; ISO:RGD.
DR   GO; GO:2000036; P:regulation of stem cell population maintenance; ISO:RGD.
DR   CDD; cd12769; RRM1_HuR; 1.
DR   CDD; cd12773; RRM2_HuR; 1.
DR   CDD; cd12653; RRM3_HuR; 1.
DR   Gene3D; 3.30.70.330; -; 3.
DR   InterPro; IPR006548; ELAD_HU_SF.
DR   InterPro; IPR002343; Hud_Sxl_RNA.
DR   InterPro; IPR034996; HuR_RRM2.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   NCBIfam; TIGR01661; ELAV_HUD_SF; 1.
DR   PANTHER; PTHR10352; EUKARYOTIC TRANSLATION INITIATION FACTOR 3 SUBUNIT G; 1.
DR   Pfam; PF00076; RRM_1; 3.
DR   PRINTS; PR00961; HUDSXLRNA.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF54928; RNA-binding domain, RBD; 2.
DR   PROSITE; PS50102; RRM; 3.
PE   1: Evidence at protein level;
KW   Acetylation; Cytoplasm; Isopeptide bond; Methylation; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; RNA-binding; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q15717"
FT   CHAIN           2..326
FT                   /note="ELAV-like protein 1"
FT                   /id="PRO_0000436065"
FT   DOMAIN          20..98
FT                   /note="RRM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          106..186
FT                   /note="RRM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          244..322
FT                   /note="RRM 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15717"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15717"
FT   MOD_RES         100
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15717"
FT   MOD_RES         158
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15717"
FT   MOD_RES         197
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15717"
FT   MOD_RES         202
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         206
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P70372"
FT   MOD_RES         217
FT                   /note="Asymmetric dimethylarginine; by CARM1; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q15717"
FT   MOD_RES         217
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q15717"
FT   MOD_RES         221
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15717"
FT   MOD_RES         318
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15717"
FT   CROSSLNK        191
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q15717"
SQ   SEQUENCE   326 AA;  36169 MW;  74A98DEE5B921AF6 CRC64;
     MSNGYEDHMA EDCRDDIGRT NLIVNYLPQN MTQEELRSLF SSIGEVESAK LIRDKVAGHS
     LGYGFVNYVT AKDAERAIST LNGLRLQSKT IKVSYARPSS EVIKDANLYI SGLPRTMTQK
     DVEDMFSRFG RIINSRVLVD QTTGLSRGVA FIRFDKRSEA EEAITSFNGH KPPGSSEPIT
     VKFAANPNQN KNMALLSQLY HSPARRFGGP VHHQAQRFRF SPMGVDHMSG ISGVNVPGNA
     SSGWCIFIYN LGQDADEGIL WQMFGPFGAV TNVKVIRDFN TNKCKGFGFV TMTNYEEAAM
     AIASLNGYRL GDKILQVSFK TNKSHK
//
